MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Free Cash flow
-$7,079,712
Unit: Dollar
Positive Cash Flow Breakdown
    • Proceeds from issuance of notes ...
    • Proceeds from sale of preferred ...
    • Proceeds from sale of common sto...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Accounts payable and accrued lia...
    • Purchases of property and equipm...
    • Others
Cash Flow
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Realized losses, net, on investment securities
-
-
-
0
Net loss
-7,063,136
-4,222,850
-3,429,124
-6,843,054
Depreciation
140,000
75,078
75,140
141,690
Amortization of right-of-use assets
195,542
94,187
91,894
220,911
Stock-based compensation
641,871
11,479
-211,279
327,174
Common stock issued in exchange for compensation and services
455,351
-
-
-
Change in fair value of derivative liability
22,187
-
-
-
Pik interest accretion a-1 note
16,096
-
-
-
Fair value of shares issued in exchange for services
-
99,040
-
-
Ammortization of debt discount and issuance costs
35,410
-
-
-
Shares issued in exchange for services
-
-
99,040
-
Non-cash effect of reverse stock split
-
704
-
-
Ammortization of debt issuance costs b-note
6,983
-
-
-
Advances, deposits, and other current assets
-115,860
-64,071
-155,713
26,277
Realization of deferred income tax asset
-
-
-
0
Accounts payable and accrued liabilities
-1,532,422
320,230
-1,222,467
381,116
Net cash used in operating activities
-7,010,632
-3,657,101
-4,441,083
-5,798,440
Proceeds from sale and maturity of investment securities
-
-
-
0
Purchases of property and equipment
69,080
3,589
0
276,983
Purchases of investment securities
-
-
-
0
Net cash used in investing activities
-69,080
-3,589
0
-276,983
Proceeds from sale of common stock, net of issuance costs
842,704
7,190,819
3,473,513
2,963,738
Proceeds from sale of preferred stock, net of issuance costs
2,288,025
-
-
-
Proceeds from issuance of common stock upon exercise of warrants
-
1
3,467,694
-
Proceeds from issuance of notes payable, net of issuance costs
7,034,102
-
-
-
Proceeds from issuance of common stock upon exercise of warrants
-
-
-
1,967,694
Issuance costs of stock dividend
-
0
10,277
-
Exercise of pre-funded warrants, net
1,800
-
-
-
Net cash (used in) provided by financing activities
10,163,031
7,190,820
4,963,236
4,931,432
Net change in cash, cash equivalents and restricted cash
3,083,319
3,530,130
522,153
-1,143,991
Cash, cash equivalents and restricted cash at beginning of period
8,781,059
5,250,929
5,872,767
-
Cash , cash equivalents and restricted cash at end of period
11,864,378
8,781,059
5,250,929
-
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from issuance ofnotes payable, net of...$7,034,102 Proceeds from sale ofpreferred stock, net of...$2,288,025 Proceeds from sale ofcommon stock, net of...$842,704 (-71.57%↓ Y/Y)Net cash (used in)provided by financing...$10,163,031 (106.09%↑ Y/Y)Canceled cashflow$1,800 Net change in cash,cash equivalents and...$3,083,319 (369.52%↑ Y/Y)Canceled cashflow$7,079,712 Exercise of pre-fundedwarrants, net$1,800 Stock-based compensation$641,871 (96.19%↑ Y/Y)Common stock issued inexchange for...$455,351 Amortization of right-of-useassets$195,542 (-11.48%↓ Y/Y)Depreciation$140,000 (-1.19%↓ Y/Y)Advances, deposits, andother current assets-$115,860 (-540.92%↓ Y/Y)Ammortization of debt discountand issuance costs$35,410 Pik interestaccretion a-1 note$16,096 Ammortization of debt issuancecosts b-note$6,983 Net cash used inoperating activities-$7,010,632 (-20.91%↓ Y/Y)Net cash used ininvesting activities-$69,080 (75.06%↑ Y/Y)Canceled cashflow$1,607,113 Net loss-$7,063,136 (-3.22%↓ Y/Y)Purchases of property andequipment$69,080 (-75.06%↓ Y/Y)Accounts payable andaccrued liabilities-$1,532,422 (-502.09%↓ Y/Y)Change in fair value ofderivative liability$22,187

Imunon, Inc. (IMNN)

Imunon, Inc. (IMNN)